Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of norazithromycin

A technology of norazithromycin and erythromycin, which is applied in the preparation of sugar derivatives, chemical instruments and methods, sugar derivatives, etc., can solve the problems of reduced purity, small equipment investment, low production efficiency, etc., and reduce acidic ineffective decomposition , Slow down the release speed and save production cost

Active Publication Date: 2017-09-08
HEBEI GUOLONG PHARMA CO LTD
View PDF13 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Disadvantages: Large investment in equipment, use of precious metal catalysts, poor handling of reactants, prone to catalyst poisoning, resulting in high production costs
In addition, during the experiment, our research group found that norazithromycin was unstable in acidic water, methanol, and acetonitrile. At room temperature, impurities appeared and the purity decreased; In the process of preparing norazithromycin with hydrogen, side reactions inevitably occur, and the yield is low, which affects the quality of the final azithromycin product
[0010] Use chemical reagents to reduce imido ether to prepare norazithromycin, the reaction is carried out under normal pressure, and the equipment investment is small; but due to the acid hydrolysis and neutralization process, there are partial reversible reactions to generate norazithromycin borate and bisnorazithromycin borate 2 an intermediate product, resulting in cumbersome separation steps, multiple organic solvent extractions are required, and the production efficiency is low.
In addition, the sodium borohydride disclosed in the literature is a reducing agent, requires methanol as a solvent, and operates at low temperature. The amount of sodium borohydride is large, and the production cost is high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of norazithromycin
  • Preparation method of norazithromycin
  • Preparation method of norazithromycin

Examples

Experimental program
Comparison scheme
Effect test

reference example 1-1

[0046] Reference example 1-1: Preparation of erythromycin thiocyanate A oxime (III)

[0047] Add hydroxylamine hydrochloride (114g, 1.64mol) and 300g methanol to a 1000mL three-necked flask, stir at room temperature, and add triethylamine dropwise to adjust pH=6.3-6.7. Add erythromycin thiocyanate A(II) (200g, 0.25mol), raise the temperature to 30-35°C and react for 4h, add triethylamine dropwise during the reaction to adjust the pH=6.5±0.2; raise the temperature to 50-55°C, and continue to keep warm Reaction 48h. Cool down to 15-20°C, add 600mL deionized water dropwise, stir for 0.5h; crystallize at 0-5°C for 2h. Filter, wash with 200 mL of deionized water, and dry to obtain 180 g of white solid erythromycin A oxime thiocyanate (III). Yield 88.4%, melting point 182-185°C, purity 93.7% (HPLC).

reference example 1-2

[0048] Reference example 1-2: preparation of erythromycin thiocyanate A oxime (III)

[0049] Add hydroxylamine hydrochloride (228g, 3.3mol) and 600g methanol to a 2000mL three-necked flask, stir at room temperature, and add triethylamine dropwise to adjust the pH to 6.3-6.7. Add erythromycin thiocyanate A(II) (400g, 0.5mol), heat up to 30-35°C, and keep warm for 10h; add triethylamine dropwise during the reaction to adjust pH=6.5±0.2; heat up to 50-55°C, Continue the insulation reaction for 40h. Cool down to 15-20°C, add 1200mL deionized water dropwise, stir for 0.5h; 0-5°C, crystallize for 2h. Filter, wash with 400mL deionized water, and dry to obtain 348g of white solid erythromycin A oxime thiocyanate (III), with a yield of 87.0%, a melting point of 182-184°C, and a purity of 93.8% (see HPLC figure 1 and shown in Table 1).

[0050] The HPLC detection result of table 1 erythromycin A oxime thiocyanate

[0051] peak# keep time area area% high Separatio...

reference example 2

[0053] Reference example 2: Preparation of erythromycin A imine ether

[0054] Add erythromycin A oxime thiocyanate (III) (180 g, 0.22 mol) and 540 mL of acetone into a 2000 mL three-necked flask, and stir. 0-10°C, add 450g of 10% sodium bicarbonate solution, below 5°C, add p-toluenesulfonyl chloride (51g, 0.27moL) dropwise, after 1h, keep warm for 3h. 1200 mL of deionized water was added dropwise to the reaction solution, adjusted to pH=11-12 with 10 wt % NaOH aqueous solution, and stirred for 1 h. Crystallize at 0-5°C for 1h. Filter, wash with 400 mL deionized water at room temperature, and dry to obtain 142 g of white solid erythromycin A imine ether. Yield 88.3%, melting point 134-140 ℃, purity 92.9% (see HPLC figure 2 and shown in Table 2).

[0055] The HPLC detection result of table 2 erythromycin A imine ether

[0056] peak# keep time area area% high Separation Tailing factor Theoretical plate# 1 2.606 35405.142 2.508 4299 0.000 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention discloses a preparation method of norazithromycin and relates to the technical field of macrolide antibiotics. The preparation method comprises the following steps: reducing erythrocin A 6,9-imino ether in water at 0 DEG C to room temperature under the pH of 7.0-9.0 by using a reducing agent sodium borohydride or potassium borohydride; then in the presence of an organic solvent and water, performing continuous hydrolysis at 0 DEG C to room temperature under the pH of 2.0-3.0; then adding two-phase reaction liquids after continuous hydrolysis into an alkaline aqueous solution, adjusting the pH to be greater than or equal to 12, stirring, layering and abandoning the aqueous phase, wherein the organic solvent is dichloromethane, chloroform, 1,2-dichloromethane, ethyl acetate or butyl acetate; and after the last hydrolysis reaction in continuous hydrolysis, performing layering, directly adding the aqueous phase into the alkaline aqueous solution, adjusting the pH to be greater than or equal to 12, and performing stirring and separating out norazithromycin. The method increases the utilization ratio of the reducing agent, can control reverse reactions of borate, and reduces unnecessary separating process to obtain high quality norazithromycin.

Description

technical field [0001] The invention relates to the technical field of preparation of macrolide antibiotics, in particular to a method for preparing azithromycin precursor norazithromycin. Background technique [0002] Azithromycin is a structural modification of the macrolide antibiotic erythromycin. It is broad-spectrum antibacterial and effective against certain pathogenic bacteria resistant to β-lactam antibiotics. It has the characteristics of strong tissue penetration, high concentration, and long half-life. . Clinically, it is widely used in the treatment of respiratory tract, urinary system, skin and soft tissue diseases caused by sensitive pathogenic bacteria infection, and can also be used in the treatment of sexually transmitted diseases to prevent the transmission of sexually transmitted diseases. Norazithromycin is a precursor for the preparation of azithromycin, which is methylated to give azithromycin. [0003] The preparation process of azithromycin include...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07H17/00C07H1/00
Inventor 付德才李志伟刘丽星王丽云郭李珉
Owner HEBEI GUOLONG PHARMA CO LTD